Position in EXEL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,384,063
+$2,508,603 QoQ
Shares Held
78,901
+295.0% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Integrated Wealth Concepts LLC holds $33,789,797 across 56 Biotechnology names. EXEL ranks #3 (10.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
85,447 | $4,826,901 | |
| 2 | INVA |
Innoviva, Inc.
|
165,214 | $3,849,486 | |
| 3 | EXEL |
Exelixis, Inc.
This page
|
78,901 | $3,384,063 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,201 | $3,245,860 | |
| 5 | INCY |
Incyte Corp
|
23,056 | $2,170,030 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,668 | $2,084,448 | |
| 7 | DNLI |
Denali Therapeutics Inc.
|
99,554 | $1,911,436 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,374 | $1,778,095 |
All Filings in EXEL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,384,063 | 78,901 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $875,460 | 19,974 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $461,486 | 11,174 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $634,840 | 14,402 | Shares | Other | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||